KYMR FY 2022 Earnings — Kymera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

KYMRKymera Therapeutics, Inc.

$7B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$47M-35.7% YoY

Gross Profit

$47M100.0% margin

Operating Income

-$161M-344.4% margin

Net Income

-$155M-330.6% margin

EPS (Diluted)

$-2.87

Cash Flow

Operating Cash Flow

-$153M

Free Cash Flow

-$156M

Stock-Based Comp.

$35M

Balance Sheet

Total Assets

$603M

Total Liabilities

$113M

Stockholders' Equity

$490M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47M	$73M	-35.7%
Gross Profit	$47M	$73M	-35.7%
Operating Income	-$161M	-$101M	-60.4%
Net Income	-$155M	-$100M	-54.5%